Tissue engineering is a rapidly expanding field that aims to establish feasible techniques to fabricate biologically equivalent replacements for diseased and damaged tissues/organs. Emerging from this prospect is the development of in vitro representations of organs for drug toxicity assessment. Due to the ever-increasing interest in ocular drug delivery as a route for administration as well as the rise of new ophthalmic therapeutics, there is a demand for physiologically accurate in vitro models of the eye to assess drug delivery and safety of new ocular medicines. This review summarizes current existing ocular models and highlights the important factors and limitations that need to be considered during their use.
CITATION STYLE
Shafaie, S., Hutter, V., Cook, M. T., Brown, M. B., & Chau, D. Y. S. (2016, April 1). In Vitro Cell Models for Ophthalmic Drug Development Applications. BioResearch Open Access. Mary Ann Liebert Inc. https://doi.org/10.1089/biores.2016.0008
Mendeley helps you to discover research relevant for your work.